Eikonoklastes Therapeutics, Inc.
Pharmaceutical company · Cincinnati, Ohio, United States
Eikonoklastes Therapeutics, Inc. is a pharmaceutical company headquartered in Cincinnati, Ohio, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $14 million sold in a notice filed in 2025.
Eikonoklastes Therapeutics at a glance
What does Eikonoklastes Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $13.6 million sold (2025).
Frequently asked questions about Eikonoklastes Therapeutics
Where is Eikonoklastes Therapeutics headquartered?
Eikonoklastes Therapeutics, Inc. is headquartered in Cincinnati, Ohio, United States.
What does Eikonoklastes Therapeutics do?
Eikonoklastes Therapeutics, Inc. is a pharmaceutical company.
When was Eikonoklastes Therapeutics founded?
The earliest incorporation on record for Eikonoklastes Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Procter & GambleCincinnati, Ohio, United States
- Onconetix, Inc.Cincinnati, Ohio, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences